Archived publications
We have archived all publications relating to the Prostheses List. You can find these on the National Library of Australia's web archive.
Resources
Prescribed List of Medical Devices and Human Tissue Products
This page lists the benefits for medical devices and human tissue products private health insurers must pay to patients who have appropriate insurance policies. The latest version of the Prescribed List is effective from 1 July 2026.
Surgical guides and biomodels post-listing review - Draft report
The draft departmental report summarises the review process and outcomes. Stakeholders can provide feedback on the proposed recommendations.
Cost Recovery Implementation Statement (CRIS) – Administration of the Prescribed List of Medical Devices and Human Tissue Products 2026-2027
The CRIS draft for consultation provides information on how we implement cost recovery charging for applications for medical devices seeking to be listed on the Prescribed List of Medical Devices and Human Tissue Products.
Cost Recovery Implementation Statement – Australian Orthopaedic Association National Joint Replacement Registry 2025–2029
This Cost Recovery Implementation Statement (CRIS) describes how the Department of Health, Disability and Ageing (the Department) recovers the costs of administering the Australian Orthopaedic Association National Joint Replacement Registry (AOANJRR).
Health technology assessment committee members – conflicts of interest process guide
A guide for health technology assessment committee members and department staff on the declaration, assessment, management and recording of conflicts of interest. Covering member nomination, appointment and terms of service.
Spinal cord stimulator post-listing review – Draft report
The draft department report is to summarise the review process to date and outline the proposed recommendations. The report is provided as a draft for stakeholder feedback on the proposed recommendations.
Spinal fusion cages
These documents clarify claiming benefits for spinal fusion cage devices in product group 13.10.01 on the Prescribed List and list the spinal fusion cages under integral fixation.
Prescribed List post-listing review framework
We have developed a Prescribed List Post-listing Review Framework that is used to guide the post-listing review process as part of the Prescribed List Reforms.
Prescribed List grouping schemes
View the grouping schemes for devices in Part A, Part C and Part D of the Prescribed List.
PL reforms – summary of objectives and achievements
The Prescribed List reforms finished in June 2025. This document list the reforms objectives and achievements.
Interim Evaluation #2 of the Prescribed List Reforms
This interim evaluation report 2 covers the period from July 2024 to June 2025. It builds on the interim evaluation report 1.
Prescribed List Post-Listing review – Consultants report
This report informs stage 2 of the post-listing review of surgical guides and biomodels.
Prescribed List Compliance Strategy – Safeguarding the Prescribed List
The below document outlines Prescribed List compliance obligations for relevant stakeholders and the Australian Government.
Consultation Paper 10 – General Use Items utilisation, expenditure and integrity
This circular is to advise stakeholders of the publication of a high level summary and individual submissions.
Advice on the benefit reductions to Cardiac Implantable Electronic Devices
The document contains advice on the third and final reduction of benefits for Cardiac Implantable Electronic Devices (CIED) effective 1 July 2025.
Stakeholder feedback summary – Consultation Paper 9 – CIED and the cost of technical support services
This document provides a high-level summary of stakeholder feedback received in response to Consultation Paper 9 – CIED and the cost of technical support services.
Interim Evaluation #1 of the Prescribed List Reforms
The interim evaluation report covers the period from May 2021 to June 2024 and reports on whether the reforms being implemented and achieving the expected outcomes.
Reforms to the Prescribed List Part B – Analysis of stakeholder feedback
This report is to provide an analysis of stakeholder feedback received.
Baseline evaluation of the Prostheses List reforms – Final report
This evaluation focuses on the Prostheses List reforms, which are running from 1 July 2021 to 30 June 2025. Evaluation of these reforms will determine whether the reform program is being implemented as intended.
Prescribed List billing codes – Removal of medicine and medicine accessories – 1 November 2024
This list includes details of the 26 billing codes for medicines and related accessories scheduled to be removed from Part D of the Prescribed List effective 1 November 2024.
Consultation Paper 8b – Alignment of amount charged for supply of a device with corresponding PL benefit
This report provides an analysis of stakeholder feedback received in response to the consultation paper on the proposed measure: alignment of amount charged for supply of a device with corresponding PL benefit.
Consultation Paper 7 – Proposed measures for compliance, assurance and information sharing
This report provides an analysis of stakeholder feedback received in response to the Consultation Paper on the proposed Compliance, Assurance and Information sharing measures for the Prescribed List (PL).
Consultation Paper 8a – Gifts, benefits and discounts reporting requirement
This report provides an analysis of stakeholder feedback received in response to the consultation paper on the proposed measure: Prescribed List (PL) gifts, benefits and discounts reporting requirements.
16:21
Prescribed List – practical tips on submitting applications
This webinar recording provides practical tips on submitting applications.
Prostheses List Post-Listing review – Consultants report
This report is a review of surgical guides and biomodels currently listed on the Prostheses List.
Date last updated: